CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 90 filers reported holding CUREVAC N V in Q1 2021. The put-call ratio across all filers is 1.24 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $170,878 | -64.5% | 25,011 | -45.6% | 0.00% | – |
| Q2 2023 | $481,693 | -77.5% | 45,987 | -71.1% | 0.00% | -100.0% |
| Q2 2022 | $2,142,000 | -27.2% | 159,247 | +5.3% | 0.00% | – |
| Q1 2022 | $2,943,000 | -35.0% | 151,169 | +15.0% | 0.00% | -100.0% |
| Q4 2021 | $4,527,000 | -67.3% | 131,424 | -48.0% | 0.00% | -60.0% |
| Q3 2021 | $13,837,000 | -72.0% | 252,569 | -62.4% | 0.01% | -73.7% |
| Q2 2021 | $49,420,000 | +270.9% | 672,301 | +361.4% | 0.02% | +216.7% |
| Q1 2021 | $13,326,000 | -23.8% | 145,695 | -32.4% | 0.01% | -33.3% |
| Q4 2020 | $17,482,000 | +678.7% | 215,644 | +347.2% | 0.01% | +800.0% |
| Q3 2020 | $2,245,000 | – | 48,221 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,625,943 | $11,332,823 | 10.01% |
| RA Capital Management | 12,245,955 | $85,354,306 | 1.93% |
| Avidity Partners Management LP | 3,550,000 | $24,743,500 | 0.82% |
| Camber Capital Management LP | 1,250,000 | $8,713 | 0.27% |
| Ghisallo Capital Management LLC | 100,000 | $697,000 | 0.17% |
| FOX RUN MANAGEMENT, L.L.C. | 31,278 | $218,008 | 0.07% |
| Alyeska Investment Group, L.P. | 1,060,382 | $7,390,863 | 0.06% |
| Green Alpha Advisors, LLC | 12,351 | $86,086 | 0.06% |
| Virtus ETF Advisers LLC | 14,114 | $98,375 | 0.05% |
| Quantamental Technologies LLC | 11,146 | $77,688 | 0.04% |